Clinical Trial Update: Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a combination of biological therapy and monoclonal antibody therapy in patients with relapsed or refractory Non-Hodgkin lymphoma; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Lymphoma | Phase 1 | Status: COMPLETED